3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Leukemia, Myeloid, Acute
22
Precursor Cell Lymphoblastic Leukemia-Lymphoma
21
Leukemia, Lymphocytic, Chronic, B-Cell
21
Congenital Abnormalities
21
Leukemia
20
Lymphoma, Follicular
19
Lymphoma, B-Cell, Marginal Zone
19
Breast Neoplasms
19
Multiple Myeloma
17
Lymphoma, Mantle-Cell
17
Myelodysplastic Syndromes
15
Lymphoma, Non-Hodgkin
15
Lymphoma, Large B-Cell, Diffuse
15
Myeloproliferative Disorders
13
Lymphoma, Large-Cell, Immunoblastic
13
Lymphoma
13
Burkitt Lymphoma
13
Blast Crisis
13
Lymphoma, T-Cell, Cutaneous
12
Leukemia, Myelomonocytic, Chronic
12
Leukemia, Myeloid, Accelerated Phase
12
Sezary Syndrome
11
Mycosis Fungoides
11
Leukemia, Myeloid, Chronic-Phase
11
Neoplasms, Plasma Cell
10
Hodgkin Disease
10
Waldenstrom Macroglobulinemia
9
Primary Myelofibrosis
9
Pdgfra-Associated Chronic Eosinophilic Leukemia
8
Leukemia, Neutrophilic, Chronic
8
Interventions
Whole-Body Irradiation
6
Peripheral Blood Stem Cell Transplantation
6
Biopsy
6
fludarabine phosphate
5
Immunohistochemistry
5
Epoetin Alfa
5
Cyclophosphamide
5
Tacrolimus
4
Methotrexate
4
Gene Expression Profiling
4
Celecoxib
4
Mycophenolic Acid
3
Microarray Analysis
3
Imiquimod
3
Etoposide
3
Darbepoetin alfa
3
Cyclosporine
3
Colposcopy
3
Busulfan
3
Antilymphocyte Serum
3
Aminolevulinic Acid
3
Tomography, Optical Coherence
2
Sirolimus
2
Polymerase Chain Reaction
2
Methylprednisolone
2
Melphalan
2
Mass Spectrometry
2
Immunoenzyme Techniques
2
Filgrastim
2
Fatty Acids, Omega-3
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Precancerous Conditions
×
Flow Cytometry
×
Clear all
NCT00629577
2017-02-01
SAGE
British Columbia Cancer Agency
Phase 1
Terminated
50 enrolled